我国各地基本药物增补情况分析  

Analysis of the situation of additional essential medicines in Chinese different regions

作　　者：李跃平[1,2] 林莉[1] 黄子杰[1,3] 黎彩芳[1] 

机构地区：[1]福建医科大学公共卫生学院卫生管理与社会医学系,福州350004 [2]福建医科大学卫生政策研究中心,福州350004 [3]泉州师范学院,福建泉州362000

出　　处：《药学服务与研究》2012年第2期90-93,共4页Pharmaceutical Care and Research

基　　金：2011年度福建省社会科学规划项目(No.2011B113)

摘　　要：目的:了解我国各地基本药物增补数量及其种类,为各地及国家制定和调整基本药物增补目录提供信息和依据。方法:采用直线相关分析法分析各省基本药物增补量与当地人均国民生产总值(GDP)之间的关系;采用频数分析法比较样本省增补的基本药物的数量、类别、品名等方面的同异等。结果:各省增补的基本药物数量与当地的人均GDP呈正相关(r=0.575,P=0.001);样本省增补的化学药品和生物制品中,抗微生物药品占增补总数的13.91%,中成药中清热剂占增补总数的18.17%;有59种药品被6个以上的省份增补,其中化学药品和生物制品有43种,中成药有16种。结论:社会经济状况影响各地基本药物的增补数量,各地基本药物的增补存在较为明显的趋同性,并以抗微生物药和清热剂的增补为主。Objective： To provide information and evidence for framing and optimizing additional essential medicine lists（AEMLs） by investigating the amounts and categories of additional essential medicines （AEMs） in different regions of China. Methods： The rela tionship between the amount of AEMs and the local per capita gross domestic product（GDP） was analyzed by linear correlation method. The differences of amounts, categories and names, etc. of AEMs in different provinces were compared by frequency analysis. Results： Positive relation between the amount of AEMs and the local per capita GDP（r= 0. 575, P= 0. 001） was observed. In the additional chemical drugs and biological products of sample provinces,the antimicrobial agents accounted for 13.91%,and the heat clearing pre- scriptions accounted for 18.17% among the Chinese patent medicines. Fifty-nine drugs were added to the lists in more than 6 provinces, including 43 kinds of chemical drugs and biological products and 16 kinds of the Chinese patent medicines. Conclusion： The amount of AEMs is affected by the local social and economical conditions. Obvious convergence of AEMs in different regions is observed. The AEMs are mainly antimicrobial agents and the heat-clearing prescriptions.

关 键 词：基本药物 增补情况 人均GDP 

分 类 号：R197.1[医药卫生—卫生事业管理]